A recent article drawing attention to the "inadequate, inaccurate or outdated" product information available for thyroid-related drugs prompted letters from several of our readers.
The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.
Correspondence:
Online responses are no longer available. Please refer to our instructions for authors page for more information.